THE SINGLE BEST STRATEGY TO USE FOR AML RISK SCORE

In older patients undergoing induction therapy with hypomethylating agent + venetoclax, the median response time ranges from one.Adults that are deemed unfit for therapy may well acquire the most effective supportive treatment. If individuals accomplish full remission, the hypomethylating agent + venetoclax routine might be ongoing indefinitely,